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ABSTRACT Chronic inflammatory diseases of the airways are associated with gastro-oesophageal reflux
(GOR) and aspiration events. The observation of lipid-laden macrophages (LLMs) within the airway may
indicate aspiration secondary to GOR. The proposed mechanism, that lipid droplets from undigested or
partially digested food are aspirated leading to accumulation in scavenging macrophages, led us to
hypothesise that an activated population of LLMs could interact with other immune cells to induce
bronchial inflammation.
To test this, we generated an in vitro model using differentiated THP-1 cells, which were treated with a
high-fat liquid feed.
Here, we show that THP-1 cells can take up lipid from the high-fat feed independent of actin
polymerisation or CD36-dependent phagocytosis. These cells did not exhibit M1 or M2 polarisation. Gene
array analysis confirmed over 8000 genes were upregulated by at least twofold following high fat exposure,
and IL-8 was the most upregulated gene. Pathway analysis revealed upregulation of genes known to be
involved in chronic obstructive pulmonary disease (COPD) pathophysiology.
We suggest that aspiration and macrophage phagocytosis may be important mechanisms in the
aetiology of diseases such as COPD and cystic fibrosis that are characterised by high levels of IL-8 within
the airways.
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ORIGINAL ARTICLE
MECHANISMS OF LUNG DISEASE
Introduction
Gastro-oesophageal reflux (GOR) is epidemiologically associated with a number of diseases of the airways.
It is commonly reported in chronic obstructive pulmonary disease (COPD) exacerbations, cystic fibrosis
(CF) and non-CF bronchiectasis, and has been implicated in ∼50% of difficult-to-treat asthma cases [1, 2].
GOR may be defined by retrograde transport of gastric contents and may comprise liquid alone or more
commonly a mixture of liquid and gaseous or particulate reflux [3]. Ascent of stomach contents into the
upper airways, pharynx and beyond has been variously labelled as extra-oesophageal reflux,
laryngo-pharyngeal reflux or, more recently, airway reflux. Aspiration into the upper and lower airways
causes pneumonia, bronchitis and rhinitis, but the mechanism whereby aspiration induces the
inflammatory cascade has not previously been addressed.
The inhaled refluxate consists of aerosolised stomach acid, bile, partially digested food matter, bacteria as
well as many other constituents including proteolytic enzymes such as pepsin [3–6]. Homogenised lipids
are also present in refluxate and can be detected following ingestion by alveolar macrophages using
established lipid-staining techniques [7]. A recent study using lipid staining of macrophages from
bronchoalveolar lavage fluid found a strong association between lipid-laden macrophages (LLMs) and
GOR, but not asthma [8]. The macrophage is capable of scavenging lipid, but the mechanism of fatty acid
internalisation and lipid droplet formation is still largely unknown [9–11]. It is recognised that passive
diffusion may occur by insertion of the hydrophobic fatty acids into the external surface of the plasma
membrane followed by a “flip-flop” mechanism, through which the lipid enters the cytoplasm. By contrast,
circulating lipid in the form of low-density lipoprotein (LDL) is known to enter the macrophage via both
actin-dependent and -independent mechanisms of endocytosis [12]. Whether this is also true in the case of
exogenous, unpackaged fatty acids remains unknown. Macrophages express the class A scavenger receptor
and the oxidised LDL scavenger receptor CD36 [13], both of which are capable of binding modified LDL.
In the circulation this leads to “foam cell” formation and the arterial wall changes of atherosclerosis.
M1 macrophages are classically activated by bacteria and are usually associated with a cell-mediated
inflammatory response [14]. M2 polarised macrophages are alternatively activated and are normally associated
with resolution and tissue repair [15]. In atherosclerotic plaques, both classically and alternatively activated
cells (M1 and M2, respectively) are present. The polarisation of the macrophage may respond to and modulate
different stages of the disease [16, 17]. In the lung, the presence of lipid-laden alveolar macrophages in sputum
or on brochoalveolar lavage has been reported to be indicative of aspiration secondary to GOR [18–21].
Specificity is, however, limited, because intracellular lipid accumulation may occur in other inflammatory
processes such as pneumonia. Although studies have been carried out on the mode of uptake of circulating
modified LDL in foam cells, alveolar macrophage lipid uptake has so far been overlooked.
We hypothesise that lipid droplets present in airway reflux may be aspirated and accumulate in scavenging
alveolar macrophages. Foam cell formation would thus generate activated macrophages, propagating an
immune response by the release of inflammatory cytokines, in turn causing airway inflammation and
remodelling. Obtaining primary alveolar macrophages can be difficult, so models such as phorbol 12-myristate
13-acetate (PMA) treated THP-1 cells are routinely used and accepted as a satisfactory model [22–24]. Using
the human monocytic leukaemia cell line, THP-1, stimulated with PMA to induce monocyte-to-macrophage
differentiation [25], we investigated the activation status of LLMs generated by the uptake of unmodified lipid
and compared this to classically and alternatively activated macrophages. In addition, we investigated the mode
of uptake of unmodified lipid by the macrophage by inhibiting actin-dependent phagocytosis and by blocking
the CD36 scavenger receptor. Finally, we elucidated the change in gene expression and cytokine profile
consequent on lipid uptake.
Methods
Cell culture
THP-1 cells were maintained in RPMI 1640 with 10% fetal bovine serum, penicillin (100 U·mL−1) and
streptomycin (0.1 mg·mL−1) (Gibco, Paisley, UK). Cells (0.5×106 cells·mL−1) were differentiated in medium with
50 nM PMA (24 h) then PMA-free medium (24 h) before further treatments. Differentiation (PMA/THP-1)
was determined by cell adherence, increased nucleus-to-cytoplasm ratio, and mitotic growth inhibition.
Lessons for clinicians
• Alveolar macrophages may be able to accumulate dietary lipids following aspiration into the lungs.
• Lipid-laden macrophages display altered gene transcription and could interact with other immune cells
to induce bronchial inflammation.
• Thus, aspiration and macrophage phagocytosis may be important mechanisms in the aetiology of
diseases including COPD.
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Oil Red O staining
PMA/THP-1 cells were incubated with 10% Calogen, the medical high-fat liquid food (Nutricia Advanced
Medical Nutrition, Wiltshire, UK) for 24 h. Staining of intracellular lipid droplets was performed using the
Oil Red O (ORO) stain. This stain is more soluble in lipid than in aqueous solvent, staining nonpolar
lipids a bright red colour. A stock solution of ORO (0.5% in isopropanol) was diluted and filtered (60%
stock solution and 40% distilled water). Slides were stained (20 min) and counterstained (3 min) with
Mayer’s haematoxylin followed by two to three drops of 0.1% sodium bicarbonate (30 s). Slides were dried
and mounted using Kaiser’s glyceringelatine mounting medium.
Assessment of phagocytosis
PMA/THP-1 cells were incubated with 1 mg·mL−1 zymosan (1 h) and stained using a Reastain Quick-Diff
Kit (Reagena Ltd, Toivala, Finland). Phagocytosed zymosan appeared as white rings in the cellular
cytoplasm and was quantified using the phagocytic index.
PMA/THP-1 cells were incubated in medium containing 10 μg·mL−1 cytochalasin D or mouse monoclonal
CD36 clone FA6-152 blocking antibody (1 μg·mL−1; Santa Cruz, Heidelberg, Germany) for 1 h before
incubation with zymosan (1 h) or Calogen (4 h). Coverslips were then differentially stained or stained
with ORO.
Transmission electron microscopy
Cells were harvested then fixed in iso-osmotic 2.5% glutaraldehyde diluted in sodium cacodylate buffer
(pH 7.3) and post-fixed in 1% osmium tetroxide. Cells were then stained with 1% uranyl acetate and
dehydrated through an ethanol series and eventually propylene oxide. Cells were embedded in epon resin
and ultrathin sections were cut. Images were obtained in a Jeol 2010 transmission electron microscope
(TEM) running at 120 kV using a Gatan US4000 digital camera.
Gene microarray
mRNA (duplicates of four) was extracted using a NucleoSpin® RNA II Kit (Macherey-Nagel, Duren,
Germany) and quantified on a Qubit™ fluorometer (Invitrogen, Paisley, UK) before gene expression
profiling and analysis (Bioscience Technology Facility, University of York), using an Agilent gene array
system. Data were analysed through the use of QIAGEN’s Ingenuity Pathway Analysis (IPA, QIAGEN
Redwood City, www.qiagen.com/ingenuity).
ELISAs
PMA/THP-1 cells were either left untreated or treated to induce M1 (lipopolysaccharide, 10 ng·mL−1) or
M2 (IgG, 150 ng·mL−1 or M-CSF, 50 ng·mL−1) cell polarisation. Release of IL-4, IL-8, IL-12 and β-NGF
was measured by ELISA (R&D Systems, Abingdon) (detection range 31.2–2000 pg·mL−1 for all kits). Plates
were analysed on a Multiskan FC plate-reader (Thermo Scientific) at 450 nm, subtracting readings at
570 nm to correct for plate optical imperfections.
Flow cytometry
Cells were harvested, counted and filtered through a 70 µm cell strainer (BD Biosciences), and transferred
to 96-well tissue culture plates at a concentration of 1×105 cells per well. The plate was centrifuged (350g,
3 min, 4 °C) and washed twice with PBS before incubating (30 min at 4 °C) with mouse monoclonal
primary antibodies (CD11b, CD14, CD16, CD23, CD24, CD32, CD36, CD64, CD80, CD86, CD163, CD206
(20 µg·mL−1, AbD Serotec, Oxford, UK) or CD32 [26]). Cells were washed with PBS and centrifuged (350g,
5 min, 4 °C) twice and the supernatant discarded. The cells were then incubated with fluorescein
isothiocyanate (FITC)-conjugated rabbit anti-mouse IgG secondary antibody (50 µg·mL−1, Sigma Aldrich,
Poole, UK) with gentle agitation (30 min at 4 °C in the dark). The cells were washed as previously described
and re-suspended in 500 µL FACSFlow Buffer (BD Biosciences) before analysis on a FACSAria II flow
cytometer (BD Biosciences) running BD FACSDiva version 6.1.3 software and counting 1×104 cells per
sample. During analysis, a gate (P1) was applied to the live cell population based on forward side-scatter
characteristics. This gate was applied to a histogram of fluorescence to all subsequent samples within the
same experiment, and statistical data were generated to include mean fluorescence intensities.
Statistical analysis
Data are expressed as means±SEM. For the assessment of phagocytosis, an unpaired, two-tailed t-test was
performed for samples with unequal variance (Microsoft Excel 2010). An independent sample
Kruskal–Wallis test was performed to highlight significant differences in cell surface expression following
treatments, followed by Mann–Whitney testing (SPSS v19; IBM, Armonk, NY, USA). For the gene
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microarray analysis, significance is displayed as the p-values corrected (p-value (corr)) for multiple testing
using the Benjamini–Hochberg FDR (false discovery rate) method.
Results
Assessment of phagocytosis
Initially, we sought to determine whether PMA-differentiated THP-1 cells accumulated lipid from
Calogen, a medical high-fat liquid feed. Indeed, PMA-differentiated THP-1 cells were able to take up lipid
following exposure to Calogen (figure 1a and b). Next we investigated possible mechanisms of lipid
uptake, either via phagocytosis or CD36 receptor mediated lipid uptake. Cytochalasin D, a fungal
metabolite, binds to actin filaments and inhibits actin polymerisation, thus inhibiting actin dependent
phagocytosis. CD36 is a scavenger receptor which is involved in lipid uptake and foam cell formation. In
order to assess whether this receptor was involved in lipid uptake in our model, we inhibited CD36 using
a monoclonal CD36 blocking antibody. Pre-incubation with cytochalasin D and CD36 blocking antibody
failed to inhibit lipid uptake by PMA/THP-1 cells (figure 1c and d) despite the cytochalasin D inhibiting
zymosan uptake by these cells (supplementary figure S1). These cells were visualised under TEM
(figure 1e). Identified lipid droplets were then magnified for closer inspection (figure 1f and g). Lipid
droplets were visible randomly throughout the cytoplasm and were identifiable by dark staining of residual
lipid remaining after the fixing process. These droplets could be differentiated from cholesterol clefts
formed by crystallisation of cholesterol during the fixation procedure, visible as long clear spaces in the
cytoplasm. Closer inspection revealed what appears to be a double membrane surrounding the lipid
droplet which was variable in size and shape although roughly rounded.
Gene microarray data analysis
Uptake of lipids by macrophages is known to initiate a signalling cascade within the cells, which may
initiate an inflammatory response. We therefore used gene microarrays to compare gene expression pre-
and post-lipid exposure in PMA-differentiated THP-1 cells. This was followed by pathway analysis to
identify possible signalling pathways induced by the lipid uptake. Microarray data are available in the
a) b) c) d)
e) f) g)
FIGURE 1 PMA/THP-1 lipid uptake. PMA/THP-1 cells were incubated with 10% vol/vol Calogen for 24 h with and without inhibitors and were
stained with ORO to detect lipid accumulation. a) Untreated cells were compared with b) cells treated with Calogen alone and c) in the presence
of cytochalasin D and d) CD36 monoclonal blocking antibody. Inset images are magnified representative regions of each treatment. e) Cells
treated with Calogen were also visualised under TEM. Scale bar=1 μm. f, g) Lipid droplets were identified and magnified to reveal dark stained
remnants of lipid encased in membrane-bound vesicles, as indicated by the arrows. Scale bars=500 nm (f ) and 100 nm (g).
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ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-4153. PMA
treatment of THP-1 cells induced 8130 genes to be upregulated or downregulated by twofold or more.
Upon Calogen stimulation of PMA/THP-1 cells, 8502 genes showed fold change differences of two or
more compared with PMA treatment alone. The majority of these genes (5396) showed two- to threefold
differences. Table 1 shows the top 10 upregulated and downregulated genes for Calogen-treated PMA/
THP-1 cells compared to PMA/THP-1 cells alone. Interestingly, in addition to these genes, IL-1β was also
upregulated 32-fold following lipid treatment. The top 10 upregulated and downregulated genes in PMA/
THP-1 cells compared to THP-1 cells alone are shown in supplementary table S1 (note that some genes
are probed for twice, including IL-8 and CCL4). Gene functions were adapted from the NCBI gene
database and the GeneCards human gene database index.
TABLE 1 Top 10 up- and downregulated genes following Calogen treatment of PMA/THP-1 cells
Fold change Gene symbol Description Direction p-value (corr)
971 IL8 Homo sapiens interleukin 8 (IL8), mRNA [NM_000584] – a neutrophil
chemotactic cytokine
↑ 3.07×10−10
86 ANGPTL4 Homo sapiens angiopoietin-like 4 (ANGPTL4), transcript variant 1,
mRNA [NM_139314] – modulates glucose homeostasis and lipid
metabolism
↑ 2.80×10−7
63 CXCL3 Homo sapiens chemokine (C-X-C motif ) ligand 3 (CXCL3), mRNA
[NM_002090] – neutrophil chemoattractant
↑ 9.63×10−12
56 FBXW10 Homo sapiens F-box and WD repeat domain containing 10 (FBXW10),
mRNA [NM_031456] – a protein ubiquitin ligase
↑ 4.39×10−8
46 CCL20 Homo sapiens chemokine (C-C motif) ligand 20 (CCL20), transcript
variant 1, mRNA [NM_004591] – involved in inflammation,
lymphocyte chemotactic activity
↑ 5.13×10−5
45 GPR56 Homo sapiens G protein-coupled receptor 56 (GPR56), transcript
variant 3, mRNA [NM_201525]
↑ 1.95×10−5
42 ADORA2A Homo sapiens adenosine A2a receptor (ADORA2A), mRNA
[NM_000675] – a GPCR with multiple roles, implicated in
inflammatory diseases
↑ 7.78×10−8
40 CCL4 Homo sapiens chemokine (C-C motif) ligand 4 (CCL4), transcript
variant 1, mRNA [NM_002984] – mitogen-inducible monokine with
inflammatory functions
↑ 5.43×10−7
39 IL8 Interleukin 8 [Source: HGNC Symbol; Acc:6025] [ENST00000401931]
– a neutrophil chemotactic cytokine
↑ 6.49×10−11
38 CCL4 Homo sapiens chemokine (C-C motif) ligand 4 (CCL4), transcript
variant 1, mRNA [NM_002984] – mitogen-inducible monokine with
inflammatory functions
↑ 5.34×10−7
108.3 XLOC_000604 UI-E-EJ1-ajw-b-14-0-UI.r1 UI-E-EJ1 Homo sapiens cDNA clone
UI-E-EJ1-ajw-b-14-0-UI 5′, mRNA sequence [BQ188485] –
unknown
↓ 8.28×10−9
78.5 MS4A6A Homo sapiens membrane-spanning 4-domains, subfamily A,
member 6A (MS4A6A), transcript variant 2, mRNA [NM_022349] –
may be involved in signal transduction
↓ 2.47×10−7
72.0 GPA33 Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA
[NM_005814] – possibly involved in cell–cell recognition
↓ 6.52×10−7
71.0 MS4A6A Homo sapiens membrane-spanning 4-domains, subfamily A,
member 6A (MS4A6A), transcript variant 1, mRNA [NM_152852] –
may be involved in signal transduction
↓ 3.97×10−6
55.2 MRVI1 Homo sapiens murine retrovirus integration site 1 homologue
(MRVI1), transcript variant 2, mRNA [NM_130385] – multiple roles
including regulation of IP3-induced calcium release
↓ 4.06×10−12
42.4 CX3CR1 Homo sapiens chemokine (C-X3-C motif ) receptor 1 (CX3CR1),
transcript variant 4, mRNA [NM_001337] – CX3C receptor involved
in its adhesion and migratory functions
↓ 5.43×10−10
40.7 GPR34 Homo sapiens G protein-coupled receptor 34 (GPR34), transcript
variant 4, mRNA [NM_001097579] – exact function unknown
↓ 9.87×10−12
38.5 ENHO Homo sapiens energy homeostasis associated (ENHO), mRNA
[NM_198573] – role in glucose homeostasis and lipid metabolism
↓ 2.52×10−6
30.5 LOC100505633 Homo sapiens uncharacterised LOC100505633,
non-coding RNA [NR_038849] – unknown function
↓ 9.37×10−8
29.8 MNDA Homo sapiens myeloid cell nuclear differentiation antigen (MNDA),
mRNA [NM_002432] – may regulate transcription in myeloid cells
↓ 8.80×10−8
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Data were analysed through the use of QIAGEN’s Ingenuity Pathway Analysis (IPA) (QIAGEN, Redwood
City, CA, USA), which revealed that Calogen treatment of PMA/THP-1 cells induced an increase in
expression in a number of genes important in the development of COPD (figure 2). These genes include
IL-8, TNF-α, CXCL2 and MMPs 8 and 1.
Analysis of the gene array data for markers of macrophage polarisation, following Calogen treatment,
showed a trend towards M2 polarisation, with increases in IL-8 and CD23 genes and decreases in M1
markers (CD16, CD32 and CD64 genes).
ELISA cytokine analysis
Released cytokines were measured using ELISAs to determine whether the lipid-treated PMA/THP-1 cells
displayed an M1 or M2 phenotype. PMA/THP-1 cells were either left untreated or treated to induce M1
(PMA or LPS) or M2 (IgG or M-CSF) cell polarisation. IL-4 production was used to detect M2 macrophage
polarisation. Concentrations of IL-4 were detected at very low levels (around 100 pg·mL−1) in all
supernatants taken from THP-1 cell cultures, with no significant difference between treatments (figure 3a).
Very low levels of the neutrophil chemoattractant protein, IL-8, were detected in untreated THP-1 cell
culture samples. In samples taken from PMA/THP-1 cell culture, IL-8 protein concentrations were
significantly higher following all treatments (figure 3b). Treatment with Calogen did not further increase
IL-8 secretion and, although there was a slight increase in Calogen-induced IL-4 secretion, this was not
significant. Levels of both IL-12, the M1 macrophage marker, and NGF, were undetectable (data not shown).
Immunophenotype of polarised and LLMs
THP-1 cells were left untreated or stimulated to differentiate with PMA. PMA/THP-1 cells were then
stimulated to become M1 or M2 polarised activated macrophages with either LPS (M1), heat-aggregated
human IgG (M2) or M-CSF (M2, data not shown). PMA/THP-1 cells were also treated with Calogen
before comparing key cell surface markers (supplementary table S2 gives a description of each marker),
known to be indicators of M1 or M2 polarised macrophages (figure S2), by flow cytometry. Compared
with THP-1 cells treated with PMA only, PMA plus LPS-treated cells were not significantly different. Cells
treated with PMA plus heat-aggregated human IgG differed from cells treated only with PMA by a
significantly decreased expression of CD32 only. This reduction was not seen in M-CSF-treated PMA/
THP-1 cells, which displayed a significantly lower expression of CD163 when compared with
PMA-only-treated cells (data not shown). Calogen-treated cells also showed no significant difference when
compared with PMA-only-treated cells. When compared with PMA plus LPS-treated cells, Calogen-treated
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FIGURE 2 Gene microarray pathway analysis. The analysis revealed that Calogen treatment of PMA/THP-1
cells caused upregulation (shaded boxes) of genes associated with the development of COPD (the network
was generated using QIAGEN’s Ingenuity Pathway Analysis (IPA); QIAGEN, Redwood City, CA, USA).
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cells showed significantly higher CD14 expression and lower CD32 expression. Finally, when compared
with PMA plus heat-aggregated human IgG-treated cells, Calogen-treated cells were not different.
Discussion
Alveolar macrophages make up ∼70% of the immune cells populating the airway and are capable of
antigen presentation and modulation of the immune response. The alveolar macrophage is also capable of
lipid uptake, which may activate and induce an inflammatory phenotype by mechanisms currently
unknown. We hypothesised that lipid droplets from aerosolised gastric contents, when aspirated into the
airway, accumulate in scavenging macrophages. LLM formation in the airway may thus generate activated
macrophages that interact with other immune cells and tissue to induce an airway inflammation and
fibrosis characteristic of a number of different respiratory conditions.
PMA/THP-1 incubated with 10% vol/vol Calogen were stained using ORO and showed intense lipid
staining. This staining is probably due to the direct uptake of lipids from the Calogen, as little or no staining
was detected in the PMA/THP-1-only cells. Calogen was used in this study because of the high standard of
manufacturing process used in products for human consumption, and because aspiration of Calogen feed is
a particularly common clinical scenario during nasogastric and enteral feeding. Calogen contains a
combination of sunflower oil and canola oil, which comprise varying combinations of both long-chain
unsaturated (89.4%) and long-chain saturated (10.6%) fatty acids, along with a small amount of trans fats.
Upon visualisation by TEM, accumulated lipid droplets were separate from, and in addition to, cholesterol
clefts. They appeared to be randomly distributed throughout the cytoplasm, bearing no obvious association
to specific organelles or structures, suggesting passive diffusion through the cell membrane rather than the
previously hypothesised endogenous production from the endoplasmic reticulum [9].
In order to decipher the mechanism by which lipids can be internalised by macrophages, we inhibited
actin-dependent phagocytosis by incubation with cytochalasin D. Cytochalasin D is a fungal metabolite
that binds actin filaments to prevent polymerisation. When PMA/THP-1 were pre-incubated with
cytochalasin D before incubation with Calogen, lipid uptake was unaffected. Cells were also pre-incubated
with a commercially available antibody clone capable of blocking CD36. This also appeared to have no
effect on lipid accumulation. There are a number of different ways for macrophages to take up lipids
(summarised by [27]). In this study we were unable to identify the exact mechanism; however, our results
suggest that internalisation of lipids is actin-independent and in agreement with the hypothesis that fatty
acids can diffuse across cells membranes. The TEM pictures showed that the lipids were present within the
cytosol and appeared to be surrounded by a double membrane that could indicate autophagy. Once inside
the cell, the lipids may be encapsulated, creating autophagosomes that are degraded by lysosomes [28].
Upon Calogen stimulation, 8502 genes were upregulated twofold or greater in PMA/THP-1 cells. The
majority of these genes (5398) were two- to threefold different. The present results indicate that lipid uptake
has a direct effect on cell mRNA transcription and may provide clues as to potential therapeutic manipulation
of this process. Pathway analysis revealed that the Calogen treatment of PMA/THP-1 cells upregulated genes
involved in the development of airway inflammation and fibrosis. Our findings suggest future experimental
approaches into the pathophysiology of airways disease resulting from macrophage lipid accumulation.
IL-8 was probed for and detected in all samples by ELISA. In untreated THP-1 cell culture supernatant,
levels of IL-8 were particularly low. However, when THP-1 cells were stimulated with PMA, IL-8 levels were
significantly raised, regardless of the secondary stimulation. It is possible therefore that PMA stimulation of
THP-1 cells causes IL-8 secretion, which masks any further secretion induced by a secondary stimulant.
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FIGURE 3 IL-4 and IL-8 secretion by THP-1 cells. Concentrations of a) IL-4 and b) IL-8 protein detected
by ELISA in cell culture supernatants of THP-1 cells subjected to a variety of treatments. PMA: phorbol
12-myristate 13-acetate; LPS: lipopolysaccharide. *: p<0.05.
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Indeed PARK et al. showed that similar PMA concentrations induced IL-8 mRNA upregulation [29]. As
neutrophilic infiltration of the airways is a clinical feature of many non-atopic inflammatory airways
diseases, including those induced by infection, this finding was perhaps not surprising. However, in our
experiments, at the mRNA level IL-8 was most upregulated in Calogen-treated PMA/THP-1 cells. IL-8 is
known to be prestored in other cell types including endothelial cells [30], and this may also be true for
monocytes and macrophages. We thus suggest that, on PMA exposure, intracellular stores are depleted and
no further release can be seen with other stimulants such as Calogen. At the mRNA level, however,
Calogen causes an upregulation of IL-8 message contributing to replenishment of the intracellular stores.
This is a novel mechanism whereby neutrophilic airway inflammation, such as occurs in exacerbations of
COPD and “neutrophilic asthma”, may be generated in the absence of an infectious stimulus.
We generated in vitro cell cultures of activated macrophages polarised to both the M1 inflammatory
phenotype (using LPS) and the M2 anti-inflammatory phenotype (using heat-aggregated human IgG or
M-CSF) in order to compare with the LLMs generated by Calogen treatment. On stimulation with
heat-aggregated human IgG, we expected PMA/THP-1 cells to polarise to an anti-inflammatory M2
macrophage phenotype with increased expression of the IgE receptor (CD23), upregulation of the
haemoglobin and mannose receptors (CD163 and CD206) and possibly with increased expression of
CD86, the co-stimulatory molecule required for TH2 cell differentiation. Heat-aggregated human
IgG-treated PMA/THP-1 cells showed only a significant decrease in CD32 compared with PMA-only
treated cells, which does not indicate cell polarisation. For this reason we compared heat-aggregated
human IgG stimulation with an alternative method for inducing M2 polarisation, namely M-CSF (data not
shown). M-CSF stimulation failed to significantly alter CD32 expression compared with PMA-only cells.
This would suggest a blocking effect seen by heat-aggregated human IgG, but no effect with M-CSF. A
small but significant reduction in CD163 was observed with M-CSF treated cells compared with controls,
which would indicate that both heat-aggregated human IgG and M-CSF were ineffective at generating M2
polarised macrophages. In addition, treatment with Calogen did not appear to significantly change the
immunophenotype of the PMA/THP-1 cells and thus could not be labelled as M1 or M2 polarised
according to recently published markers [17, 31–33]. We were also unable to detect macrophage
polarisation by measuring released cytokines. This is perhaps unsurprising, as it appears that macrophages
display plasticity and can rarely be classified into two distinct subsets [16].
Although an M2 macrophage polarisation could not be distinguished, we were encouraged by the IL-4
ELISA results produced. Although not significant here, there was a trend to an increase in IL-4 with
Calogen treatment, suggesting polarisation may be directed more towards M2. This is also true of IL-8,
another M2 marker, which, although not significantly different on ELISA, was highly upregulated on an
mRNA level, as determined by gene array analysis.
In conclusion, macrophages are able to accumulate dietary lipids in membrane-bound vesicles distributed
throughout the cell cytoplasm. This lipid uptake directly alters gene transcription, including upregulation of
IL-8, TNF-α, CXCL2 and MMPs 8 and 1, which are involved in inflammatory conditions including COPD.
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